• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Aminobenzoic acids and derivatives

Recent Advances in the Study of 4-amino-N-tert-butylbenzamide (CAS: 93483-71-7)

4-amino-N-tert-butylbenzamide (CAS: 93483-71-7) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug development, particularly as a building block for novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic uses.

One of the key areas of investigation has been the synthesis and optimization of 4-amino-N-tert-butylbenzamide. A study published in the Journal of Medicinal Chemistry (2023) detailed an improved synthetic route that enhances yield and purity, making it more feasible for large-scale production. The study highlighted the importance of this compound as an intermediate in the synthesis of more complex molecules with potential pharmacological activity.

In terms of biological activity, recent research has identified 4-amino-N-tert-butylbenzamide as a potential modulator of specific protein-protein interactions. A 2024 study in Bioorganic & Medicinal Chemistry Letters demonstrated its ability to inhibit the interaction between two key proteins involved in inflammatory pathways. This finding suggests its potential as a lead compound for developing anti-inflammatory drugs, although further in vivo studies are required to validate these effects.

Another promising avenue of research involves the use of 4-amino-N-tert-butylbenzamide in the development of kinase inhibitors. A preprint article (2024) from a leading pharmaceutical research group reported that derivatives of this compound showed selective inhibition against certain tyrosine kinases, which are often implicated in cancer. The study utilized computational modeling and high-throughput screening to identify the most promising derivatives for further development.

Despite these advances, challenges remain in the clinical translation of 4-amino-N-tert-butylbenzamide-based therapeutics. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed. A recent review in Expert Opinion on Drug Discovery (2023) discussed these challenges and proposed strategies to overcome them, including structural modifications and formulation improvements.

In conclusion, 4-amino-N-tert-butylbenzamide (CAS: 93483-71-7) continues to be a compound of significant interest in pharmaceutical research. Its versatility as a building block and its emerging biological activities make it a promising candidate for further investigation. Future research should focus on optimizing its pharmacological properties and exploring its potential in various therapeutic areas.

• 5894-65-5(N-tert-Butylbenzamide)
• 54977-92-3(4-Amino-N-benzylbenzamide)
• 89399-17-7(4-Amino-N-ethylbenzamide)
• 38681-77-5(N-Cyclopropyl 4-Aminobenzamide)
• 90252-29-2(Benzamide, N-(1,1-dimethylethyl)-, compd. with benzene (1:1))
• 774-67-4(4-amino-N-(propan-2-yl)benzamide)
• 42498-32-8(N-(tert-Butyl)-4-methylbenzamide)
• 81882-62-4(3-Amino-N-isopropylbenzamide)
• 827346-47-4(Benzamide,N-butyl-3,5-dimethyl-)
• 90252-31-6(Benzamide, N-(1,1-dimethylethyl)-, compd. with methylbenzene (1:1))